Integrate systemic therapy in treatment of HPV-associated OPSCC.
Identify indications for postoperative RT and postoperative chemoradiotherapy.
Use a range of acceptable doses/fractionation schemes for definitive and postoperative RT and discuss achievable target metrics for organs-at-risk sparing in treatment planning for bilateral and ipsilateral neck treatment.
